Medicine
EPFL startup develops system for producing blood platelets on demand
TechTransfer
EPFL
Blood platelets can be stored for only up to a week, and hospitals often run short of this life-saving resource. To help overcome this problem, an EPFL startup called HemostOD has developed technology that can produce blood platelets in large volumes and on demand.
Drug combo breaks down cancer resistance to immunotherapy
Research
EPFL
By combining a checkpoint inhibitor with a new immunocytokine, scientists at EPFL, Ludwig Institute for Cancer Research, CHUV and Roche have made a breakthrough in fighting against immunotherapy-resistant cancers.
Acids help against airborne viruses
Research
ETH Zurich EPFL
A new study by various Swiss universities shows that aerosols in indoor air can vary in acidity. This acidity determines how long viruses remain infectious in the air – with profound implications for virus transmission and strategies to contain it.
More Precise Treatment
Research
ETH Zurich
The LOOP Zurich research center combines expertise from ETH Zurich, the University of Zurich and the four university hospitals in Zurich with the aim of developing more personalized therapies. Two new projects supported by The LOOP Zurich target urinary tract infections and obesity respectively.
A sensitive drill
Research
Empa
Hearing-impaired people whose auditory nerve is still intact can often be helped with a cochlear implant. But inserting the implant into the inner ear is not without risks, as facial nerves can be damaged in the process. Empa researchers have developed a novel smart drill that minimizes the risk by automatically shutting off when it comes near nerves.
Diagnosing diseases with a puff of breath
Research
ETH Zurich
A needle and some blood are usually needed for medical diagnostics.
Page 22 of 33